Age differences in presentation, diagnosis pathway and management of colorectal cancer

Cancer Epidemiology

Volumn 38, Issue 4, 2014, Pages 346-353

  Esteva, Magdalena ^a   Ruiz, Amador ^a   Ramos, Maria ^b   Casamitjana, Monserrat ^c   Sánchez Calavera, María A ^d   González Luján, Luis ^e   Pita Fernández, Salvador ^f   Leiva, Alfonso ^a   Pértega Díaz, Sonia ^f,p   Costa Alcaraz, Ana M ^g   Macià, Francesc ^h   Espí, Alejandro ^i,p   Segura, Josep M ^j   Lafita, Sergio ^k   Novella, Maria T ^l   Yus, Carmen ^m   Oliván, Barbara ⁿ   Cabeza, Elena ^o   Seoane Pillado, Teresa ^f   López Calviño, Beatriz ^f   Llobera, Joan ^a   Martin Rabadan M Maria ^p   Teresa Novella, María ^p   Ripoll, Joana ^p   Manzano, Hermini ^p   Amengual, Isabel ^p   Forteza, Aina ^p   Company, Maria ^p   De Lluch Bennassar, Maria ^p   Sánchez, Maria Antónia ^p   Magallón, Rosa ^p   Olivan, Barbara ^p   Maciá, Francesc ^p   Pita, Salvador ^p   Louro, Arturo ^p   Serrano, Joaquín ^p   Arnal, Francisco ^p   González Santamaría, Paloma ^p   Seoane, Teresa ^p   González Lujan, Luis ^p   Costa Alcaraz, Ana ^p   Bosca, Marta M ^p   Balza, Nelly ^p   Villagrasa, Rosa A ^p   Vázquez, Juan F ^p   González Timoneda, y Alba ^p   more..

^a Balearic Department of Health   (Spain)

^b Balearic Department of Health   (Spain)

^c Parc Sanitari Pere Virgili Edifici Mestral   (Spain)

^d Canal Imperial Primary Care Centre   (Spain)

^e UNIVERSITAT POLITÈCNICA DE VALÈNCIA   (Spain)

^f HOSPITAL JUAN CANALEJO   (Spain)

^g Nazareth Health Centre   (Spain)

^h HOSPITAL DEL MAR   (Spain)

ⁱ HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^j Lluis Saye Primary Care Centre   (Spain)

^k Fraga Primary Health Center   (Spain)

^l HOSPITAL CAN MISSES   (Spain)

^m HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

ⁿ UNIVERSITY OF ZARAGOZA   (Spain)

^o Balearic Department of Health   (Spain)

^p NONE

more..

Author keywords

Colorectal cancer; Early diagnosis; Elderly; Health services accessibility; Primary health care; Quality of health care; Secondary care; Treatment

Indexed keywords

AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER STAGING; COLORECTAL CANCER; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; ECHOGRAPHY; FEMALE; FOLLOW UP; HEALTH CARE QUALITY; HUMAN; INCIDENCE; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MULTICENTER STUDY; MULTIMODALITY CANCER THERAPY; PERCEPTION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; ADULT; CLINICAL TRIAL; COLORECTAL NEOPLASMS; HEALTH CARE DISPARITY; MIDDLE AGED; ONSET AGE; SPAIN; VERY ELDERLY;

ADULT; AGE OF ONSET; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; CROSS-SECTIONAL STUDIES; FEMALE; HEALTHCARE DISPARITIES; HUMANS; MALE; MIDDLE AGED; SPAIN;

EID: 84904553174     PISSN: 18777821     EISSN: 1877783X     Source Type: Journal    
DOI: 10.1016/j.canep.2014.05.002     Document Type: Article

References (47)

1. Cabanes Domenech A., Pérez-Gómez B., Aragonés N., Pollán M., López-Abente G. La situación del cáncer en España, 1975-2006 2009, Centro Nacional de Epidemiología, ISCIII, Madrid.
2. Sanoff H.K., Carpenter W.R., Stürmer T., Goldberg R.M., Martin C.F., Fine J.F., et al. Effect of adjuvant chemotherapy on survival of patients with stage III colon cancer diagnosed after age 75 years. J Clin Oncol 2012, 30:2624-2634.
3. Chirlaque M.D., Salmeron D., Ardanaz E., Galceran J., Martínez R., Marcos-Gragera R., et al. Cancer survival in Spain: estimate for nine major cancer. Ann Oncol 2010, 21(Suppl. 3):iii21-iii29.
4. Quaglia A., Tavilla A., Shack L., Brenner H., Janssen-Heijnen M., Allemani C., et al. The cancer survival gap between elderly and middle-aged patients in Europe is widening. Eur J Cancer 2009, 45(6 (Sp. Iss. SI)):1006-1016. Eurocare Working Group.
5. Turner N.J., Harward R.A., Mulle G.P., Selby P.J. Cancer in old age-is it inadequately investigated and treated. BMJ 1999, 319:309-311.
6. Singh H., Daci K., Petersen L.A., Collins C., Petersen N.J., Shethia A., et al. Missed opportunities to initiate endoscopic evaluation for colorectal cancer diagnosis. Am J Gastroenterol 2009, 104:2543-2544.
7. Smith L.K., Pope C., Botha J.L. Patients' help-seeking experiences and delay in cancer presentation: a qualitative synthesis. Lancet 2005, 366:825-831.
8. Robertson R., Campbell N.C., Smith S., Donnan P.T., Sullivan F., Duffy R., et al. Factors influencing time from presentation to treatment of colorectal cancer and breast cancer in urban and rural areas. Br J Cancer 2004, 90:1479-1485.
9. González Hermoso F., Perez-Palma J., Marchena-Gómez J., Lorenzo-Rocha N., Medina Arana V. Can early diagnosis of symptomatic colorectal cancer improve the prognosis?. World J Surg 2004, 28:716-720.
10. Neal R., Algar V. Sociodemographic factors and delays in the diagnosis of six cancers: analysis of data from the 'National Survey of NHS Patients: Cancer'. Br J Cancer 2005, 92:1971-1975.
11. Surgery for colorectal cancer in elderly patients: a systematic review Colorectal Cancer Collaborative Group. Lancet 2000, 356:968-974.
12. Latkauskas T., Rudinskaité G., Kurtinaitis J., Janciauskiene R., Tamelis A., Saladzinskas Z., et al. The impact of age on post-operative outcomes of colorectal cancer patients undergoing surgical treatment. BMC Cancer 2011, 5:153.
13. Shahir M.A., Lemmens V.E., van de Poo-Franse L.V., Voogd A.C., Martijn H., Janssen-Heijnen M.L. Elderly patients with rectal cancer have a higher risk of treatment related complications and a poorer prognosis than younger patients: a population-based study. Eur J Cancer 2006, 42:3015-3021.
14. McGory M.L. Quality indicators for the care of colorectal cancer in vulnerable elders. JAGS 2007, 55:S277-S284.
15. Esteva M., Ramos M., Cabeza E., Llobera J., Ruiz A., Pita S., et al. Factors influencing delay in the diagnosis of colorectal cancer: a study protocol. BCM Cancer 2007, 7:86. on behalf of the DECCIRE Research Group.
16. Esteva M., Leiva A., Ramos M., Pita-Fernández S., González-Luján L., Casamitjana M., et al. Factors related with symptom duration until diagnosis and treatment of symptomatic colorectal cancer. BMC Cancer 2013, 13:87. for the DECCIRE Research Group.
17. Domingo-Salvany A., Regidor E., Alonso J., Alvarez-Dardet C. Proposal for a social class measure, Working Group of the Spanish Society of Epidemiology and the Spanish Society of Family and Community Medicine. Aten Primaria 2000, 25(5):350-363.
18. Saura R.M., Gimeno V., Blanco M.C., Colomer R., Serrano P., Acea B., et al. Desarrollo de los indicadores de proceso y resultado y evaluación de la practica asistencial oncológica 2007, Plan de Calidad para el Sistema Nacional de Salud. Ministerio de Sanidad y Consumo. Agència d' Avaluació de Tecnologia i Recerca Mèdiques de Catalunya, Madrid, Informes de Evaluación de Tecnologías Sanitarias, ATTRM núm.2006/02.
19. Hemminki K., Santi I., Weires M., Thomsen H., Sundquist J., Lorenzo Bermejo J. Tumor location and patient characteristics of colon and rectal adenocarcinomas in relation to survival and TNM classes. BMC Cancer 2010, 10:688.
20. Li X., Butts C., Fenton D., King K., Scarfe A., Winget M. Utilization of oncology services and receipt of treatment: a comparison between patients with breast, colon, rectal or lung cancer. Ann Oncol 2011, 22:1902-1909.
21. Ayanian J.Z., Zaslavsky A.M., Fuchs C.S., Guadagnoli E., Creech C.M., Cress R.D., et al. Use of adjuvant chemotherapy and radiation therapy for colorectal cancer in a population-based cohort. Clin Oncol 2003, 21:1293-1300.
22. Zafar S.Y., Abernethy A.P., Abbot D.H., Grambow S.C., Marcello J.E., Henrndon J.E., et al. Comorbidity, age, race and stage at diagnosis in colorectal cancer: a retrospective, parallel analysis of two health systems. BMC Cancer 2008, 8:345.
23. Serra-Rexach J.A., Jimenez A.A., García-Alhambra M.A., Pla R., Vidán M., Rodríguez P., et al. Differences in the therapeutic approach to colorectal cancer in young and elderly patients. Oncologist 2012, 17:1277-1285.
24. Mitchell E., Mcdonald S., Campbell N.C., Weller D., Mcleod U. Influences on prehospital delay in the diagnosis of colorectal cancer: a systematic review. Br J Cancer 2008, 98:60-70.
25. Agüero F., Murta-Nascimento C., Gallén M., Andreu-García M., Pera M., Hernández C., et al. Colorectal cancer survival: results from a hospital-based cancer registry. Rev Esp Enferm Dig 2012, 104:572-577.
26. Fisher D.A., Zuling L.L., Grambow S.C., Abbott D.H., Sandler R.S., Fletcher R.H., et al. Determinants of medical system delay in the diagnosis of colorectal cancer within the veteran affairs health system. Dig Dis Sci 2010, 55:1434-1441.
27. Bharathan B., Welfare M., Borowski D.W., Mills S.J., Steen I.N., Kelly S.B. Impact of deprivation on short- and long-term outcomes after colorectal cancer surgery. Br J Surg 2011, 98:854-865. Northern Region Colorectal Cancer Audit Group (NORCCAG).
28. Wrigley H., Roderic P., George S., Smith J., Mullee M., Goddard J. Inequalities in survival from colorectal cancer: a comparison of the impact of deprivation, treatment and host factors on observed and cause specific survival. J Epidemiol Community Health 2003, 57:301-309.
29. Gatta G., Capocaccia R., Sant M., Bell C.M., Coeberg J.W., Damhuis R.A., et al. Understanding variations in survival for colorectal cancer in Europe: a EUROCARE high resolution study. Gut 2000, 47:533-538.
30. Lemmens V.E., Verheij C.D.G.W., Janssen-Heijnen M.L.G., Rutten H.J.T., Coeberg J.W.W. Mixed adherence to clinical practice guidelines for colorectal cancer in the Southern Netherlands in 2002. EJSO 2006, 321:68-73. on behalf of the GAstro-Intestinal Cancer Study Group.
31. van Leeuwen B.L., Påhlman L., Gunnarsson U., Sjövall A., Martling A. The effect of age and gender on outcome after treatment for colon carcinoma. A population-based study in the Uppsala and Stockholm region. Crit Rev Oncol Hematol 2008, 67:229-236.
32. Safarti D., Hill S., Blakely T., Robson B., Purdie G., Dennett E., et al. The effect of comorbidity on the use of adjuvant chemotherapy and survival from colon cancer: a retrospective cohort study. BMC Cancer 2009, 9:116.
33. Manchon-Walsh P., Borras J.M., Espinas J.A., Alise L. Variability in the quality of rectal cancer care in public hospitals in Catalonia (Spain): clinical audit as a basis for action. EJSO 2011, 37:325-333. on behalf of the Catalonian Rectal Cancer Group.
34. Etzioni D.A., El-Khoueiry A.B., Beart R.W. Rates and predictors of chemotherapy use for stage III colon cancer. A systematic review. Cancer 2008, 113:3279-3289.
35. Gross C.P., Guo Z., McAvay G.J., Allore H.G., Young M., Tinetti M.E. Multimorbidity and survival in older person with colorectal cancer. J Am Geriatr Soc 2006, 54:1898-1904.
36. Bouvier A.M., Jooste V., Bonnetain F., Usel M., Zellweger M., Neyroud I., et al. Adjuvant treatments do not alter the quality of life in elderly patients with colorectal cancer. Cancer 2008, 113:879-886.
37. Keating N.L., Landrum M.B., Klabunde C.N., Fletcher R.H., Roger S.O., Doucette W.R., et al. Adjuvant chemotherapy for stage III colon cancer: do physicians agree about the importance of patient age and comorbidity?. J Clin Oncol 2008, 26:2532-2537.
38. Krzyzanowska M.K., Regan M.M., Powell M., Earle C.C., Weeks J.C. Impact of patient age and comorbidity on surgeon versus oncologist preferences for adjuvant chemotherapy for stage III colon cancer. J Am Coll Surg 2009, 208:202-209.
39. Kutner J.S., Vuko, Prindiville S.A., Byers T.E. Patient age and cancer treatment decisions. Patient and physician views. Cancer Pract 2000, 8:114-119.
40. Potosky A.L., Harlan L.C., Kaplan R.S., Johnson K.A., Lynch C.F. Age, sex and racial differences in the use of standard adjuvant therapy for colorectal cancer. J Clin Oncol. 2002, 20:1192-1202.
41. Winget M., Hossain S., Yasui Y., Scarfe A. Characteristics of patients with stage III colon adenocarcinoma who fail to receive guideline-recommended treatment. Cancer 2010, 15:4849-4856.
42. Eldin N.S., Yasui Y., Scarfe A., Winget M. Adherence to treatment guidelines in stage II/III rectal cancer in Alberta, Canada. Clin Oncol (R Coll Radiol) 2012, 24:e9-e17.
43. Andersen R.S., Vedsted P., Olesen F., Bro F., Søndergaard J. Patient delay in cancer studies: a discussion of methods and measures. BMC Health Serv Res 2009, 9:189.
44. Belloc Calmet J., Porta Serra M., Malats Riera N., Gallen Castillo M., Planas Domingo J. El síntoma inicial atribuible al cáncer en los tumores del tubo digestivo, Un análisis de concordancia entre el paciente y el médico. Med Clin (Barc) 1994, 103:401-407.
45. Aldelstein B.A., Irwing L., Macaskill P., Katelaris P.H., Jones D.B., Bokey L. A self administered reliable questionnaire to assess lower bowel symptoms. BMC Gastroenterol 2008, 8:8.
46. Tate A.R., Martin A.G., Murray-Thomas T., Anderson S.R., Cassell J.A. Determining the date of diagnosis - is it a simple matter? The impact of different approaches to dating diagnosis on estimates of delayed care for ovarian cancer in UK primary care. BMC Med Res Methodol 2009, 9:42.
47. Weller D., Vedsted P., Rubin G., Walter F.M., Emery J., Scott S., et al. The Aarhus statement: improving design and reporting of studies of early diagnosis. Br J Cancer 2012, 106:1262-1267.